Cloruro Sódico Y Cloruro Potásico Baxter (Potassium Chloride, Sodium Chloride)

Cloruro Sódico Y Cloruro Potásico Baxter is used in clinical settings to correct electrolyte disturbances and support fluid management. It is commonly administered when patients need rapid restoration of sodium and potassium levels.

• Treatment of hyponatremia caused by sodium loss or dilution
• Management of hypokalemia resulting from inadequate potassium intake
• Fluid replacement during surgery or major trauma
• Support of electrolyte balance in patients receiving diuretics
• Maintenance of plasma osmolarity in critically ill patients

Side effects of Cloruro Sódico Y Cloruro Potásico Baxter may vary in frequency and severity. Monitoring during infusion helps identify and manage any adverse reactions.

Common

• Mild local irritation at the injection site
• Transient nausea or vomiting
• Temporary headache or dizziness

Serious

• Hypernatremia or hyperkalemia leading to cardiac arrhythmias
• Severe allergic reaction such as anaphylaxis
• Rapid rise in blood pressure or fluid overload

When using Cloruro Sódico Y Cloruro Potásico Baxter, clinicians should consider several safety factors to minimize risks.

• Verify patient electrolyte levels before and during infusion
• Adjust infusion rate in patients with renal impairment
• Avoid use in individuals with known hypersensitivity to sodium or potassium salts
• Monitor cardiac rhythm in patients with pre‑existing heart disease
• Use caution in patients with fluid overload or congestive heart failure
• Ensure proper aseptic technique to prevent infection

Cloruro Sódico Y Cloruro Potásico Baxter can interact with other medications that affect electrolyte balance or cardiac function. Awareness of these interactions helps prevent complications.

Avoid

• Concurrent use of high‑dose potassium‑sparing diuretics (e.g., spironolactone) that may cause hyperkalemia
• Administration with other hypertonic saline solutions that could raise sodium levels excessively
• Co‑administration with ACE inhibitors or ARBs that may increase potassium retention

Use with caution

• Concomitant use of digitalis glycosides, as electrolyte shifts can precipitate toxicity
• Simultaneous infusion of other intravenous fluids; adjust rates to avoid fluid overload